文献速递神经肿瘤

整合性跨平台分析揭示胶质母细胞瘤代谢标志为增强的代谢异养性

Integrative cross-platform analyses identify enhanced heterotrophy as a metabolic hallmark in glioblastoma.
PubMed 文献 · Neuro Oncol · 2019-01-01

本研究通过整合代谢组学与基因组学跨平台分析,比较低级别星形细胞瘤(LGA,n=28)与胶质母细胞瘤(n=80)的代谢重编程。研究发现胶质母细胞瘤存在以脂质、肽和氨基酸代谢异常为主的代谢程序,并表现出显著的代谢异质性;转录亚型与代谢特征紧密聚集,且代谢表型与基因表达分析揭示支持增强代谢异养性的转录程序。

要点

  • 胶质母细胞瘤与LGA的代谢程序相互排斥,脂质、肽和氨基酸代谢为恶性转化的主要代谢节点。
  • O6-甲基鸟嘌呤-DNA甲基转移酶甲基化和异柠檬酸脱氢酶突变状态在胶质母细胞瘤代谢谱中分布均等。
  • 转录亚型与代谢特征紧密聚集,前神经型和间充质型肿瘤代谢谱相互排斥。

核心结论

  • 尽管驱动胶质母细胞瘤进展的分子通路不同,维持其侵袭性表型的代谢程序保持保守,这促成了增强的代谢异养性状态以支持在不同微环境中的生存。

研究设计与样本

  • 研究采用整合性跨平台分析,将全局代谢组学分析与基因组学结合,纳入患者来源的低级别星形细胞瘤(LGA,n=28)和胶质母细胞瘤(n=80)组织。
  • 在临床前模型中对鉴定出的代谢程序进行了代谢组学、基因组学和功能学验证。

主要发现

  • 代谢组学分析清晰区分了LGA与胶质母细胞瘤的代谢程序,其中异常的脂质、肽和氨基酸代谢代表与恶性转化相关的主要代谢节点。
  • 胶质母细胞瘤和LGA的代谢谱看似相互排斥,但胶质母细胞瘤内部观察到相当大的代谢异质性。
  • 整合分析显示O6-甲基鸟嘌呤-DNA甲基转移酶甲基化和异柠檬酸脱氢酶突变状态在胶质母细胞瘤代谢谱中分布均等。
  • 转录亚型按代谢特征紧密聚集,前神经型和间充质型肿瘤代谢谱相互排斥。
  • 将代谢表型与基因表达分析整合,发现了紧密协调且高度冗余的转录程序,通过主动从微环境输入生化底物来支持观察到的代谢程序,促成增强的代谢异养性状态。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Although considerable progress has been made in understanding molecular alterations driving gliomagenesis, the diverse metabolic programs contributing to the aggressive phenotype of glioblastoma remain unclear. The aim of this study was to define and provide molecular context to metabolic reprogramming driving gliomagenesis. METHODS: Integrative cross-platform analyses coupling global metabolomic profiling with genomics in patient-derived glioma (low-grade astrocytoma [LGA; n = 28] and glioblastoma [n = 80]) were performed. Identified programs were then metabolomically, genomically, and functionally evaluated in preclinical models. RESULTS: Clear metabolic programs were identified differentiating LGA from glioblastoma, with aberrant lipid, peptide, and amino acid metabolism representing dominant metabolic nodes associated with malignant transformation. Although the metabolomic profiles of glioblastoma and LGA appeared mutually exclusive, considerable metabolic heterogeneity was observed in glioblastoma. Surprisingly, integrative analyses demonstrated that O6-methylguanine-DNA methyltransferase methylation and isocitrate dehydrogenase mutation status were equally distributed among glioblastoma metabolic profiles. Transcriptional subtypes, on the other hand, tightly clustered by their metabolomic signature, with proneural and mesenchymal tumor profiles being mutually exclusive. Integrating these metabolic phenotypes with gene expression analyses uncovered tightly orchestrated and highly redundant transcriptional programs designed to support the observed metabolic programs by actively importing these biochemical substrates from the microenvironment, contributing to a state of enhanced metabolic heterotrophy. These findings were metabolomically, genomically, and functionally recapitulated in preclinical models. CONCLUSION: Despite disparate molecular pathways driving the progression of glioblastoma, metabolic programs designed to maintain its aggressive phenotype remain conserved. This contributes to a state of enhanced metabolic heterotrophy supporting survival in diverse microenvironments implicit in this malignancy.

来源:Neuro Oncol,查看原文。版权归原作者所有。

引用

  1. Prabhu AH, Kant S, Kesarwani P, et al. Integrative cross-platform analyses identify enhanced heterotrophy as a metabolic hallmark in glioblastoma. Neuro Oncol. 2019. PMID: 30476237. doi:10.1093/neuonc/noy185

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。